At each generation, an allele has a probability 0.005 to mutate, and one mutation is an increase or decrease of 0.005 in the value of the allele.
In general, mutation is an operation of altering one or more genes (Gen and Cheng 1997).
Defining the presence or absence of this mutation is an essential part of clinical diagnostic algorithms and patient management.
Mutation is an important operator in genetic algorithm to generate new genes by flipping one or more gene values randomly in a chromosome.
These data indicate IDH mutation is an early event in glioma oncogenesis, frequently preceding known alterations like TP53 mutation and 1p/19q loss (Watanabe et al., 2009).
Occasionally, a mutation is an improvement that makes the molecule more likely to reproduce, and the mutation spreads throughout the population.
Apolipoprotein A-I Zaragoza (apo A-I Z, L144R mutation) is an apolipoprotein A-I variant whose carriers have low HDL-cholesterol (HDL-c) concentrations but, paradoxically, no atherosclerotic symptoms despite the presence of additional atherogenic risks.
In order to overcome this limitation, we investigated whether the modification of residues significantly displaced upon the original mutation is an effective way to reduce protein aggregation in mammalian cells.
This indicates that Slbp mutation is an enhancer of PEV.
First, we show that the previously reported scattershot mutation is an allele of tre1.
For example, in the pancreas, Kras mutation is an early step in tumor initiation [5].
